neurodegenerative disease
BC Platforms Partners With Finnish Biobanks for Therapeutics Research
The company, which has its R&D center in Finland, has won a multiyear contract with three biobanks to improve access to and management of genomic and other clinical data.
Alzheimer's Disease GWAS Meta-Analysis Leads to New Susceptibility Loci, Risk Score
After identifying 75 Alzheimer's disease-associated loci, researchers explored related pathways and came up with a genetic risk score for the disease.
Fresh off a $43 million fundraising round, the drug discovery-focused bioinformatics firm is validating novel drug targets and compounds with an eye toward 2023 clinical trials.
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Alzheimer's Disease Genomes Lead to Novel Loci Involved in Synaptic Function
Starting with genome sequences for thousands of individuals from Alzheimer's-affected families, researchers found rare disease-associated variants at 13 new loci.